Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico

J Subst Use Addict Treat. 2024 May:160:209308. doi: 10.1016/j.josat.2024.209308. Epub 2024 Jan 30.

Abstract

Introduction: As a public health crisis, hepatitis C viral infection (HCV) is highly prevalent among people who inject drugs (PWID). We aimed to assess factors associated with HCV antibody (Ab) and HCV ribonucleic acid (RNA) positivity among PWID in Puerto Rico.

Methods: The study recruited a total of 150 persons in rural and peri-urban community settings through the respondent-driven sampling method and administered a structured questionnaire. We conducted HIV and HCV testing using dried blood spots (DBS). We examined correlates of HCV infection with sociodemographics, drug use patterns, and injection practices using regression in bivariate and multivariable analysis.

Results: Of the 150 participants, 89 % were male; 11 % were female; 72 % identified as mixed race; and the median duration of drug injection was 17.8 years. The mean age was 43.1 years, with 64 % of the population being from 23 to 45 years old. Among study participants (n = 150), the prevalence of HCV Ab was 73 %, and HCV RNA was 53 %. Factors significantly associated with HCV Ab and RNA included older age, increasing years of injection, incarceration, injecting other people, and identifying as Black. The belief that syringe air blowing reduces HCV transmission was also independently associated with HCV Ab positivity.

Conclusions: Our findings regarding risk factors associated with HCV infection show the need to enhance prevention and control strategies for reducing transmission among PWID. Direct-acting antiviral treatment, sustained access to harm reduction, and culturally tailored services will be required to substantially reduce rates of HCV. Community-based treatment models and treatment in correctional settings are needed.

Keywords: Dried blood spot; HCV RNA; HCV risk factors; Hepatitis; PWID; Puerto Rico.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Hepacivirus / genetics
  • Hepacivirus / immunology
  • Hepatitis C Antibodies* / blood
  • Hepatitis C* / epidemiology
  • Hepatitis C* / transmission
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Puerto Rico / epidemiology
  • RNA, Viral* / blood
  • Risk Factors
  • Substance Abuse, Intravenous* / complications
  • Substance Abuse, Intravenous* / epidemiology
  • Young Adult

Substances

  • Hepatitis C Antibodies
  • RNA, Viral